Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)

PHASE2RecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Peritoneal CarcinomatosisAppendiceal NeoplasmsColorectal Cancer Metastatic
Interventions
DRUG

Modified early post-operative intraperitoneal chemotherapy (mEPIC)

"On post-operative days 1 and 2, an abdominal reservoir is obtained by administering 1000 mL of plasmalyte with 50 mEq NaHCO3 via a Tenckhoff catheter. Participants will then receive an intraperitoneal fluorouracil bolus of 400 mg/m2 administered over 1 to 2 minutes followed by a continuous intraperitoneal fluorouracil infusion of 1200 mg/m2 over the next 24 hours. During the continuous intraperitoneal infusion of fluorouracil, 50 mg of folinic acid is administered intravenously.~After completion of mEPIC day 1, the perfusate is drained out before starting mEPIC day 2."

Trial Locations (1)

H1T 2M4

RECRUITING

Hôpital Maisonneuve-Rosemont, Montreal

All Listed Sponsors
collaborator

Maisonneuve-Rosemont Hospital

OTHER

lead

Ciusss de L'Est de l'Île de Montréal

OTHER